|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4,714.00 GBX | -1.11% |
|
+3.04% | -24.60% |
| May. 20 | WINNERS & LOSERS: AEP Plantations sinks; RS Group profit climbs | AN |
| May. 07 | Henkel Sales Rise Amid Flurry of Deals | DJ |
| Fiscal Period: December | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 13.23B | 14.45B | 14.61B | 14.17B | 14.2B | |||||
Total Revenues | 13.23B | 14.45B | 14.61B | 14.17B | 14.2B | |||||
Cost of Goods Sold, Total | 5.54B | 6.09B | 5.85B | 5.57B | 5.57B | |||||
Gross Profit | 7.69B | 8.36B | 8.76B | 8.6B | 8.63B | |||||
Selling General & Admin Expenses, Total | 4.65B | 4.64B | 5.11B | 4.99B | 4.9B | |||||
R&D Expenses | 313M | 325M | 337M | 325M | 316M | |||||
Other Operating Expenses | -75M | -14M | -3M | -172M | -2M | |||||
Other Operating Expenses, Total | 4.89B | 4.95B | 5.44B | 5.15B | 5.21B | |||||
Operating Income | 2.8B | 3.41B | 3.32B | 3.45B | 3.42B | |||||
Interest Expense, Total | -244M | -233M | -295M | -393M | -423M | |||||
Interest And Investment Income | 29M | 29M | 41M | 53M | 41M | |||||
Net Interest Expenses | -215M | -204M | -254M | -340M | -382M | |||||
Income (Loss) On Equity Invest. | -3M | -2M | - | - | - | |||||
Currency Exchange Gains (Loss) | 764M | -24M | 15M | -13M | 5M | |||||
Other Non Operating Income (Expenses) | -4M | -7M | -35M | 14M | -4M | |||||
EBT, Excl. Unusual Items | 3.34B | 3.18B | 3.04B | 3.11B | 3.04B | |||||
Restructuring Charges | -18M | - | - | -167M | -195M | |||||
Merger & Related Restructuring Charges | -14M | - | - | - | - | |||||
Impairment of Goodwill | - | -167M | -810M | -696M | - | |||||
Gain (Loss) On Sale Of Investments | - | -19M | - | - | - | |||||
Gain (Loss) On Sale Of Assets | -3.52B | 83M | 166M | - | 1.24B | |||||
Asset Writedown | -48M | - | - | -143M | -256M | |||||
Other Unusual Items | -6M | -5M | - | - | - | |||||
EBT, Incl. Unusual Items | -260M | 3.07B | 2.4B | 2.1B | 3.84B | |||||
Income Tax Expense | -208M | 711M | 753M | 672M | 635M | |||||
Earnings From Continuing Operations | -52M | 2.36B | 1.65B | 1.43B | 3.2B | |||||
Earnings Of Discontinued Operations | 31M | -7M | 9M | -4M | -16M | |||||
Net Income to Company | -21M | 2.35B | 1.66B | 1.43B | 3.19B | |||||
Minority Interest | -11M | -19M | -14M | -2M | -5M | |||||
Net Income - (IS) | -32M | 2.33B | 1.64B | 1.43B | 3.18B | |||||
Net Income to Common Incl Extra Items | -32M | 2.33B | 1.64B | 1.43B | 3.18B | |||||
Net Income to Common Excl. Extra Items | -63M | 2.34B | 1.63B | 1.43B | 3.2B | |||||
Per Share Items | ||||||||||
Net EPS - Basic | -0.05 | 3.39 | 2.39 | 2.12 | 4.88 | |||||
Basic EPS - Continuing Operations | -0.09 | 3.4 | 2.37 | 2.13 | 4.9 | |||||
Basic Weighted Average Shares Outstanding | 685M | 687M | 688M | 672M | 652M | |||||
Net EPS - Diluted | -0.05 | 3.38 | 2.38 | 2.12 | 4.87 | |||||
Diluted EPS - Continuing Operations | -0.09 | 3.39 | 2.37 | 2.12 | 4.89 | |||||
Diluted Weighted Average Shares Outstanding | 685M | 689M | 690M | 674M | 654M | |||||
Normalized Basic EPS | 3.03 | 2.86 | 2.75 | 2.89 | 2.91 | |||||
Normalized Diluted EPS | 3.03 | 2.85 | 2.74 | 2.88 | 2.9 | |||||
Dividend Per Share | 1.82 | 1.91 | 2.01 | 2.11 | 2.12 | |||||
Payout Ratio | -3.89K | 53.61 | 81.5 | 96.84 | 44.09 | |||||
American Depositary Receipts Ratio (ADR) | 0.2 | 0.2 | 0.2 | 0.2 | 0.2 | |||||
Supplemental Items | ||||||||||
EBITDA | 3.09B | 3.7B | 3.61B | 3.75B | 3.77B | |||||
EBITA | 2.87B | 3.45B | 3.35B | 3.48B | 3.49B | |||||
EBIT | 2.8B | 3.41B | 3.32B | 3.45B | 3.42B | |||||
EBITDAR | - | - | - | - | - | |||||
Effective Tax Rate - (Ratio) | 80 | 23.18 | 31.36 | 31.94 | 16.54 | |||||
Total Current Taxes | 764M | 743M | 805M | 700M | 847M | |||||
Total Deferred Taxes | -972M | -32M | -52M | -28M | -212M | |||||
Normalized Net Income | 2.08B | 1.97B | 1.89B | 1.94B | 1.9B | |||||
Interest on Long-Term Debt | 13M | 16M | 14M | 13M | 13M | |||||
Non-Cash Pension Expense | 3M | -6M | -6M | -4M | -8M | |||||
Supplemental Operating Expense Items | ||||||||||
Marketing Expenses | - | - | - | 2.16B | 2.34B | |||||
Selling and Marketing Expenses | 3.46B | 3.44B | 3.7B | 3.54B | 3.55B | |||||
General and Administrative Expenses | 1.19B | 1.2B | 1.41B | 1.46B | 1.35B | |||||
Research And Development Expense From Footnotes | 313M | 325M | 337M | 325M | 316M | |||||
Net Rental Expense, Total | - | - | - | - | - | |||||
Imputed Operating Lease Interest Expense | - | - | - | - | - | |||||
Imputed Operating Lease Depreciation | - | - | - | - | - | |||||
Stock-Based Comp., Other (Total) | 30M | 78M | 102M | 85M | 101M | |||||
Total Stock-Based Compensation | 30M | 78M | 102M | 85M | 101M |
- Stock Market
- Equities
- RKT Stock
- Financials Reckitt Benckiser Group plc
- Income Statement
Select your edition
All financial news and data tailored to specific country editions
















